ID   METK1_HUMAN             Reviewed;         395 AA.
AC   Q00266; D3DWD5; Q5QP09;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 2.
DT   15-MAR-2017, entry version 184.
DE   RecName: Full=S-adenosylmethionine synthase isoform type-1;
DE            Short=AdoMet synthase 1;
DE            EC=2.5.1.6 {ECO:0000269|PubMed:10677294};
DE   AltName: Full=Methionine adenosyltransferase 1;
DE            Short=MAT 1;
DE   AltName: Full=Methionine adenosyltransferase I/III;
DE            Short=MAT-I/III;
GN   Name=MAT1A; Synonyms=AMS1, MATA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=8393662; DOI=10.1042/bj2930481;
RA   Alvarez L., Corrales F., Mato J.M.;
RT   "Characterization of a full-length cDNA encoding human liver S-
RT   adenosylmethionine synthetase: tissue-specific gene expression and
RT   mRNA levels in hepatopathies.";
RL   Biochem. J. 293:481-486(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=1772450;
RA   Horikawa S., Tsukada K.;
RT   "Molecular cloning and nucleotide sequence of cDNA encoding the human
RT   liver S-adenosylmethionine synthetase.";
RL   Biochem. Int. 25:81-90(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 14-395 IN COMPLEX WITH
RP   S-ADENOSYL-L-METHIONINE, AND SUBUNIT.
RX   PubMed=23425511; DOI=10.1042/BJ20121580;
RA   Shafqat N., Muniz J.R., Pilka E.S., Papagrigoriou E., von Delft F.,
RA   Oppermann U., Yue W.W.;
RT   "Insight into S-adenosylmethionine biosynthesis from the crystal
RT   structures of the human methionine adenosyltransferase catalytic and
RT   regulatory subunits.";
RL   Biochem. J. 452:27-36(2013).
RN   [9]
RP   VARIANTS MATD ASP-55; PRO-305; MET-322 AND LEU-357.
RX   PubMed=7560086; DOI=10.1172/JCI118240;
RA   Ubagai T., Lei K.-J., Huang S., Mudd S.H., Levy H.L., Chou J.Y.;
RT   "Molecular mechanisms of an inborn error of methionine pathway.
RT   Methionine adenosyltransferase deficiency.";
RL   J. Clin. Invest. 96:1943-1947(1995).
RN   [10]
RP   VARIANTS MATD CYS-199; GLN-356 AND SER-378.
RX   PubMed=8770875; DOI=10.1172/JCI118862;
RA   Chamberlin M.E., Ubagai T., Mudd S.H., Wilson W.G., Leonard J.V.,
RA   Chou J.Y.;
RT   "Demyelination of the brain is associated with methionine
RT   adenosyltransferase I/III deficiency.";
RL   J. Clin. Invest. 98:1021-1027(1996).
RN   [11]
RP   VARIANT MATD HIS-264.
RX   PubMed=9042912;
RA   Chamberlin M.E., Ubagai T., Mudd S.H., Levy H.L., Chou J.Y.;
RT   "Dominant inheritance of isolated hypermethioninemia is associated
RT   with a mutation in the human methionine adenosyltransferase 1A gene.";
RL   Am. J. Hum. Genet. 60:540-546(1997).
RN   [12]
RP   VARIANTS MATD ASN-38; CYS-264; HIS-264; MET-322; ARG-336 AND ALA-344,
RP   CHARACTERIZATION OF VARIANTS MATD ASN-38; CYS-264; HIS-264; MET-322;
RP   ARG-336 AND ALA-344, CATALYTIC ACTIVITY, FUNCTION, AND PATHWAY.
RX   PubMed=10677294; DOI=10.1086/302752;
RA   Chamberlin M.E., Ubagai T., Mudd S.H., Thomas J., Pao V.Y.,
RA   Nguyen T.K., Levy H.L., Greene C., Freehauf C., Chou J.Y.;
RT   "Methionine adenosyltransferase I/III deficiency: novel mutations and
RT   clinical variations.";
RL   Am. J. Hum. Genet. 66:347-355(2000).
CC   -!- FUNCTION: Catalyzes the formation of S-adenosylmethionine from
CC       methionine and ATP. The reaction comprises two steps that are both
CC       catalyzed by the same enzyme: formation of S-adenosylmethionine
CC       (AdoMet) and triphosphate, and subsequent hydrolysis of the
CC       triphosphate. {ECO:0000269|PubMed:10677294}.
CC   -!- CATALYTIC ACTIVITY: ATP + L-methionine + H(2)O = phosphate +
CC       diphosphate + S-adenosyl-L-methionine.
CC       {ECO:0000269|PubMed:10677294}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P13444};
CC       Note=Binds 2 magnesium ions per subunit. The magnesium ions
CC       interact primarily with the substrate.
CC       {ECO:0000250|UniProtKB:P13444};
CC   -!- COFACTOR:
CC       Name=K(+); Xref=ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000250|UniProtKB:P13444};
CC       Note=Binds 1 potassium ion per subunit. The potassium ion
CC       interacts primarily with the substrate.
CC       {ECO:0000250|UniProtKB:P13444};
CC   -!- PATHWAY: Amino-acid biosynthesis; S-adenosyl-L-methionine
CC       biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1.
CC       {ECO:0000269|PubMed:10677294}.
CC   -!- SUBUNIT: Homotetramer (MAT-I); dimer of dimers (PubMed:23425511).
CC       Homodimer (MAT-III) (By similarity).
CC       {ECO:0000250|UniProtKB:P13444, ECO:0000269|PubMed:23425511}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-967087, EBI-967087;
CC       P31153:MAT2A; NbExp=4; IntAct=EBI-967087, EBI-1050743;
CC   -!- TISSUE SPECIFICITY: Expressed in liver.
CC       {ECO:0000269|PubMed:8393662}.
CC   -!- PTM: S-nitrosylation of Cys-120 inactivates the enzyme.
CC       {ECO:0000250|UniProtKB:P13444}.
CC   -!- PTM: An intrachain disulfide bond can be formed. The protein
CC       structure shows that the relevant Cys residues are in a position
CC       that would permit formation of a disulfide bond.
CC       {ECO:0000250|UniProtKB:P13444}.
CC   -!- DISEASE: Methionine adenosyltransferase deficiency (MATD)
CC       [MIM:250850]: An inborn error of metabolism resulting in isolated
CC       hypermethioninemia. Most patients have no clinical abnormalities,
CC       although some neurologic symptoms may be present in rare cases
CC       with severe loss of methionine adenosyltransferase activity.
CC       {ECO:0000269|PubMed:10677294, ECO:0000269|PubMed:7560086,
CC       ECO:0000269|PubMed:8770875, ECO:0000269|PubMed:9042912}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the AdoMet synthase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D49357; BAA08355.1; -; mRNA.
DR   EMBL; X69078; CAA48822.1; -; mRNA.
DR   EMBL; AL359195; CAI13695.1; -; Genomic_DNA.
DR   EMBL; CH471142; EAW80396.1; -; Genomic_DNA.
DR   EMBL; CH471142; EAW80397.1; -; Genomic_DNA.
DR   EMBL; BC018359; AAH18359.1; -; mRNA.
DR   CCDS; CCDS7365.1; -.
DR   PIR; S27363; S27363.
DR   RefSeq; NP_000420.1; NM_000429.2.
DR   RefSeq; XP_005269899.1; XM_005269842.4.
DR   UniGene; Hs.282670; -.
DR   PDB; 2OBV; X-ray; 2.05 A; A=16-395.
DR   PDBsum; 2OBV; -.
DR   ProteinModelPortal; Q00266; -.
DR   SMR; Q00266; -.
DR   BioGrid; 110313; 12.
DR   IntAct; Q00266; 1.
DR   STRING; 9606.ENSP00000361280; -.
DR   DrugBank; DB03191; 3-Oxiran-2ylalanine.
DR   DrugBank; DB03611; L-2-Amino-4-Methoxy-Cis-but-3-Enoic Acid.
DR   DrugBank; DB00134; L-Methionine.
DR   DrugBank; DB00118; S-Adenosylmethionine.
DR   iPTMnet; Q00266; -.
DR   PhosphoSitePlus; Q00266; -.
DR   BioMuta; MAT1A; -.
DR   DMDM; 417297; -.
DR   EPD; Q00266; -.
DR   MaxQB; Q00266; -.
DR   PaxDb; Q00266; -.
DR   PeptideAtlas; Q00266; -.
DR   PRIDE; Q00266; -.
DR   DNASU; 4143; -.
DR   Ensembl; ENST00000372213; ENSP00000361287; ENSG00000151224.
DR   GeneID; 4143; -.
DR   KEGG; hsa:4143; -.
DR   UCSC; uc001kbw.4; human.
DR   CTD; 4143; -.
DR   DisGeNET; 4143; -.
DR   GeneCards; MAT1A; -.
DR   HGNC; HGNC:6903; MAT1A.
DR   HPA; HPA048627; -.
DR   MalaCards; MAT1A; -.
DR   MIM; 250850; phenotype.
DR   MIM; 610550; gene.
DR   neXtProt; NX_Q00266; -.
DR   OpenTargets; ENSG00000151224; -.
DR   Orphanet; 168598; Brain demyelination due to methionine adenosyltransferase deficiency.
DR   PharmGKB; PA30646; -.
DR   eggNOG; KOG1506; Eukaryota.
DR   eggNOG; COG0192; LUCA.
DR   GeneTree; ENSGT00500000044811; -.
DR   HOGENOM; HOG000245710; -.
DR   HOVERGEN; HBG001562; -.
DR   InParanoid; Q00266; -.
DR   KO; K00789; -.
DR   OMA; IQDNGAV; -.
DR   OrthoDB; EOG091G08Z2; -.
DR   PhylomeDB; Q00266; -.
DR   TreeFam; TF300511; -.
DR   Reactome; R-HSA-156581; Methylation.
DR   Reactome; R-HSA-1614635; Sulfur amino acid metabolism.
DR   Reactome; R-HSA-2408508; Metabolism of ingested SeMet, Sec, MeSec into H2Se.
DR   UniPathway; UPA00315; UER00080.
DR   EvolutionaryTrace; Q00266; -.
DR   GenomeRNAi; 4143; -.
DR   PRO; PR:Q00266; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000151224; -.
DR   CleanEx; HS_MAT1A; -.
DR   ExpressionAtlas; Q00266; baseline and differential.
DR   Genevisible; Q00266; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004478; F:methionine adenosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0098601; F:selenomethionine adenosyltransferase activity; TAS:Reactome.
DR   GO; GO:0009087; P:methionine catabolic process; IMP:UniProtKB.
DR   GO; GO:0032259; P:methylation; TAS:Reactome.
DR   GO; GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0006556; P:S-adenosylmethionine biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0001887; P:selenium compound metabolic process; TAS:Reactome.
DR   GO; GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome.
DR   HAMAP; MF_00086; S_AdoMet_synth1; 1.
DR   InterPro; IPR022631; ADOMET_SYNTHASE_CS.
DR   InterPro; IPR022630; S-AdoMet_synt_C.
DR   InterPro; IPR022629; S-AdoMet_synt_central.
DR   InterPro; IPR022628; S-AdoMet_synt_N.
DR   InterPro; IPR002133; S-AdoMet_synthetase.
DR   InterPro; IPR022636; S-AdoMet_synthetase_sfam.
DR   PANTHER; PTHR11964; PTHR11964; 1.
DR   Pfam; PF02773; S-AdoMet_synt_C; 1.
DR   Pfam; PF02772; S-AdoMet_synt_M; 1.
DR   Pfam; PF00438; S-AdoMet_synt_N; 1.
DR   PIRSF; PIRSF000497; MAT; 1.
DR   SUPFAM; SSF55973; SSF55973; 3.
DR   TIGRFAMs; TIGR01034; metK; 1.
DR   PROSITE; PS00376; ADOMET_SYNTHASE_1; 1.
DR   PROSITE; PS00377; ADOMET_SYNTHASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Disease mutation;
KW   Disulfide bond; Magnesium; Metal-binding; Nucleotide-binding;
KW   One-carbon metabolism; Polymorphism; Potassium; Reference proteome;
KW   S-nitrosylation; Transferase.
FT   CHAIN         1    395       S-adenosylmethionine synthase isoform
FT                                type-1.
FT                                /FTId=PRO_0000174432.
FT   NP_BIND     179    181       ATP. {ECO:0000244|PDB:2OBV,
FT                                ECO:0000305|PubMed:23425511}.
FT   NP_BIND     247    250       ATP. {ECO:0000244|PDB:2OBV,
FT                                ECO:0000305|PubMed:23425511}.
FT   NP_BIND     264    265       ATP. {ECO:0000250|UniProtKB:P0A817}.
FT   REGION      113    125       Flexible loop.
FT                                {ECO:0000250|UniProtKB:P0A817}.
FT   METAL        23     23       Magnesium.
FT                                {ECO:0000250|UniProtKB:P13444}.
FT   METAL        57     57       Potassium.
FT                                {ECO:0000250|UniProtKB:P0A817}.
FT   BINDING      29     29       ATP. {ECO:0000244|PDB:2OBV,
FT                                ECO:0000305|PubMed:23425511}.
FT   BINDING      70     70       Methionine.
FT                                {ECO:0000250|UniProtKB:P0A817}.
FT   BINDING     113    113       Methionine.
FT                                {ECO:0000250|UniProtKB:P0A817}.
FT   BINDING     258    258       ATP. {ECO:0000244|PDB:2OBV,
FT                                ECO:0000305|PubMed:23425511}.
FT   BINDING     258    258       Methionine; shared with neighboring
FT                                subunit. {ECO:0000250|UniProtKB:P0A817}.
FT   BINDING     281    281       ATP; via amide nitrogen; shared with
FT                                neighboring subunit.
FT                                {ECO:0000250|UniProtKB:P0A817}.
FT   BINDING     285    285       ATP; shared with neighboring subunit.
FT                                {ECO:0000250|UniProtKB:P0A817}.
FT   BINDING     289    289       ATP; shared with neighboring subunit.
FT                                {ECO:0000250|UniProtKB:P13444}.
FT   BINDING     289    289       Methionine.
FT                                {ECO:0000250|UniProtKB:P0A817}.
FT   MOD_RES     120    120       S-nitrosocysteine.
FT                                {ECO:0000250|UniProtKB:P13444}.
FT   DISULFID     34     60       {ECO:0000250|UniProtKB:P13444}.
FT   VARIANT      38     38       S -> N (in MATD; abolishes enzyme
FT                                activity). {ECO:0000269|PubMed:10677294}.
FT                                /FTId=VAR_031242.
FT   VARIANT      55     55       A -> D (in MATD; dbSNP:rs118204002).
FT                                {ECO:0000269|PubMed:7560086}.
FT                                /FTId=VAR_006935.
FT   VARIANT     119    119       Q -> H (in dbSNP:rs1143693).
FT                                /FTId=VAR_028944.
FT   VARIANT     199    199       R -> C (in MATD; retains 11% of wild-type
FT                                activity; dbSNP:rs773267230).
FT                                {ECO:0000269|PubMed:8770875}.
FT                                /FTId=VAR_006936.
FT   VARIANT     264    264       R -> C (in MATD; has virtually no
FT                                enzymatic activity; dbSNP:rs118204005).
FT                                {ECO:0000269|PubMed:10677294}.
FT                                /FTId=VAR_031243.
FT   VARIANT     264    264       R -> H (in MATD; dominant mutation;
FT                                dbSNP:rs72558181).
FT                                {ECO:0000269|PubMed:10677294,
FT                                ECO:0000269|PubMed:9042912}.
FT                                /FTId=VAR_006937.
FT   VARIANT     305    305       L -> P (in MATD; dbSNP:rs118204004).
FT                                {ECO:0000269|PubMed:7560086}.
FT                                /FTId=VAR_006938.
FT   VARIANT     322    322       I -> M (in MATD; diminishes but do not
FT                                completely abolishes enzyme activity; 46%
FT                                of the level of the wild-type enzyme;
FT                                dbSNP:rs118204001).
FT                                {ECO:0000269|PubMed:10677294,
FT                                ECO:0000269|PubMed:7560086}.
FT                                /FTId=VAR_006939.
FT   VARIANT     336    336       G -> R (in MATD; retains significant
FT                                enzymatic activity; 23% of the level of
FT                                the wild-type enzyme; dbSNP:rs118204006).
FT                                {ECO:0000269|PubMed:10677294}.
FT                                /FTId=VAR_031244.
FT   VARIANT     344    344       E -> A (in MATD; diminishes but do not
FT                                completely abolishes enzyme activity; 12%
FT                                of the level of the wild-type enzyme).
FT                                {ECO:0000269|PubMed:10677294}.
FT                                /FTId=VAR_031245.
FT   VARIANT     356    356       R -> Q (in MATD; dbSNP:rs138742870).
FT                                {ECO:0000269|PubMed:8770875}.
FT                                /FTId=VAR_006940.
FT   VARIANT     357    357       P -> L (in MATD; dbSNP:rs118204003).
FT                                {ECO:0000269|PubMed:7560086}.
FT                                /FTId=VAR_006941.
FT   VARIANT     378    378       G -> S (in MATD).
FT                                {ECO:0000269|PubMed:8770875}.
FT                                /FTId=VAR_006942.
FT   CONFLICT    272    273       GG -> AA (in Ref. 2; BAA08355).
FT                                {ECO:0000305}.
FT   STRAND       18     25       {ECO:0000244|PDB:2OBV}.
FT   HELIX        30     48       {ECO:0000244|PDB:2OBV}.
FT   STRAND       53     61       {ECO:0000244|PDB:2OBV}.
FT   STRAND       64     72       {ECO:0000244|PDB:2OBV}.
FT   HELIX        79     90       {ECO:0000244|PDB:2OBV}.
FT   HELIX        95     97       {ECO:0000244|PDB:2OBV}.
FT   TURN        101    103       {ECO:0000244|PDB:2OBV}.
FT   STRAND      105    111       {ECO:0000244|PDB:2OBV}.
FT   HELIX       115    121       {ECO:0000244|PDB:2OBV}.
FT   TURN        122    124       {ECO:0000244|PDB:2OBV}.
FT   HELIX       127    129       {ECO:0000244|PDB:2OBV}.
FT   STRAND      132    134       {ECO:0000244|PDB:2OBV}.
FT   STRAND      136    143       {ECO:0000244|PDB:2OBV}.
FT   HELIX       152    170       {ECO:0000244|PDB:2OBV}.
FT   STRAND      171    173       {ECO:0000244|PDB:2OBV}.
FT   STRAND      176    191       {ECO:0000244|PDB:2OBV}.
FT   STRAND      194    209       {ECO:0000244|PDB:2OBV}.
FT   STRAND      211    213       {ECO:0000244|PDB:2OBV}.
FT   HELIX       215    224       {ECO:0000244|PDB:2OBV}.
FT   HELIX       227    230       {ECO:0000244|PDB:2OBV}.
FT   HELIX       233    235       {ECO:0000244|PDB:2OBV}.
FT   STRAND      241    245       {ECO:0000244|PDB:2OBV}.
FT   HELIX       254    256       {ECO:0000244|PDB:2OBV}.
FT   TURN        266    273       {ECO:0000244|PDB:2OBV}.
FT   HELIX       290    307       {ECO:0000244|PDB:2OBV}.
FT   STRAND      312    320       {ECO:0000244|PDB:2OBV}.
FT   STRAND      328    333       {ECO:0000244|PDB:2OBV}.
FT   HELIX       342    352       {ECO:0000244|PDB:2OBV}.
FT   HELIX       357    363       {ECO:0000244|PDB:2OBV}.
FT   TURN        364    367       {ECO:0000244|PDB:2OBV}.
FT   HELIX       371    374       {ECO:0000244|PDB:2OBV}.
FT   STRAND      375    377       {ECO:0000244|PDB:2OBV}.
FT   STRAND      379    381       {ECO:0000244|PDB:2OBV}.
FT   HELIX       386    388       {ECO:0000244|PDB:2OBV}.
SQ   SEQUENCE   395 AA;  43648 MW;  B3462A5670A5B0D4 CRC64;
     MNGPVDGLCD HSLSEGVFMF TSESVGEGHP DKICDQISDA VLDAHLKQDP NAKVACETVC
     KTGMVLLCGE ITSMAMVDYQ RVVRDTIKHI GYDDSAKGFD FKTCNVLVAL EQQSPDIAQC
     VHLDRNEEDV GAGDQGLMFG YATDETEECM PLTIILAHKL NARMADLRRS GLLPWLRPDS
     KTQVTVQYMQ DNGAVIPVRI HTIVISVQHN EDITLEEMRR ALKEQVIRAV VPAKYLDEDT
     VYHLQPSGRF VIGGPQGDAG VTGRKIIVDT YGGWGAHGGG AFSGKDYTKV DRSAAYAARW
     VAKSLVKAGL CRRVLVQVSY AIGVAEPLSI SIFTYGTSQK TERELLDVVH KNFDLRPGVI
     VRDLDLKKPI YQKTACYGHF GRSEFPWEVP RKLVF
//
